| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |